FOR IMMEDIATE RELEASE
September 22, 2007

MEDIA CONTACT
Nancy Holt, Media Coordinator
813-870-2904 § NHolt@vaxa.com

VÄXA INTERNATIONAL NAMES TOP EXECUTIVE

The Tampa-based company welcomes Gerry David as its new president

(Tampa, FL) Växa International, a leading manufacturer of homeopathic medicine, vitamins and nutritional supplements, recently announced the addition of a new corporate-level staff member. Gerry David, who has held executive positions in leading companies across the United States, joins Växa as its president.

"We are a rapidly growing company and we needed a performance-driven, forward-thinking leader with experience in long-term operational expertise and strategic thinking. Gerry was the obvious choice to lead Växa International into its future success," said Bill Harper, chief executive officer of Växa International. “He distinguishes himself with his extraordinary record of achievement and his unbridled passion for the business.”

David brings more than three decades of experience in vast aspects of the natural products and direct sales industry. A seasoned executive, he most recently served as president and COO of Vitarich Labs in Naples, Florida, where he was responsible for successfully merging the company with a public entity and increasing sales from $15 million annually to $20 million. Under his direction, the company was elevated to a GMP "A" rating status, automated production systems were implemented and software systems enhanced. David also served as chief operating office for Life Science Technologies, a start-up company funded by Roy Speer, founder of the Home Shopping Network. David extended the reach of distribution to 50 states and successfully merged the company with a public entity. He was the executive vice president of international affairs at the Home Shopping Network Direct from 1993 to 1997, managing the company’s operations in 72 countries, including overseeing the product selection and procurement process team, joint venture relationships, fulfillment operations, film production, and celebrity negotiation. Under his leadership, revenues exceeded $400 million annually.

In his new position, David will direct strategic development and execution of all Växa International initiatives, including developing expansion plans and supervising product management and distribution.

"The growth prospect that I see within this company is phenomenal,” said David, “and I look forward to being a vital part of that growth. My goal is to make Växa International a leading figure in the international natural products industry.”

About Växa International
Headquartered in Tampa, FL, Växa International is a leading manufacturer of homeopathic medicine, vitamins and nutritional supplements. Since 1987, Växa (the name is a Swedish word for re-growth or regeneration) has pioneered natural health solutions that accelerate self-healing and promote wellness. These physician-formulated products deliver some of the most powerful homeopathic medicines available by combining homeopathic principles with vitamins, minerals, amino acids, and herbal extracts. This multi-dimensional approach offers a powerful alternative to simple nutritional supplements or single-action products currently available in the industry.

Växa’s products naturally address today’s leading health challenges, including heart disease, ADD/ADHD, high blood pressure, high cholesterol, depression, arthritis, and diabetes. Several of the company’s flagship products, including TriCardia+ for cardiovascular and full-body detoxification, and Buffer-pH+ to rebalance body pH, are recognized throughout the natural health community, and approved and recommended by leading organizations. The company distributes its products to natural product retail stores, independent pharmacies and healthcare practitioners across the United States and throughout Canada, Barbados, and the Bahamas.

For more information about Växa International, call Linda Loren, Vice President of Marketing, at 813-870-2904 or visit www.vaxa.com.